ControlRad secures $15M in funding

By staff writers

October 3, 2019 -- Medical device firm ControlRad has secured $15 million in funding to further its efforts to bring its Trace radiation dose-reduction technology for fluoroscopy to market.

The funding was led by Questa Capital of San Francisco.

The U.S. Food and Drug Administration (FDA) cleared Trace for market in May. It reduces radiation exposure by up to 89%, according to the firm.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking